Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 133,675 | 105,979 | 115,886 | 103,534 | 96,800 |
| Cost of Goods | 599 | 372 | 405 | 717 | 387 |
| Gross Profit | 133,076 | 105,607 | 115,481 | 102,817 | 96,413 |
| Operating Expenses | 146,452 | 138,073 | 139,610 | 132,411 | 136,208 |
| Operating Income | -12,777 | -32,094 | -23,724 | -28,877 | -39,408 |
| Interest Expense | 2,458 | 2,234 | 2,342 | 2,084 | 1,756 |
| Other Income | 638 | 453 | 592 | 439 | 553 |
| Pre-tax Income | -14,597 | -33,875 | -25,474 | -30,522 | -40,611 |
| Net Income Continuous | -14,597 | -33,875 | -25,474 | -30,522 | -36,489 |
| Net Income | $-14,597 | $-33,875 | $-25,474 | $-30,522 | $-36,489 |
| EPS Basic Total Ops | -0.16 | -0.41 | -0.31 | -0.38 | -0.46 |
| EPS Basic Continuous Ops | -0.16 | -0.41 | -0.31 | -0.38 | -0.46 |
| EPS Diluted Total Ops | -0.16 | -0.41 | -0.31 | -0.38 | -0.46 |
| EPS Diluted Continuous Ops | -0.16 | -0.41 | -0.31 | -0.38 | -0.46 |
| EBITDA(a) | $-6,691 | $-27,200 | $-19,200 | $-24,694 | $-34,473 |